Arrowhead climbs
Sarepta Inks Global Licensing Deal With Arrowhead, Announces $500 Mln Share Buyback Program
In exchange, Arrowhead will receive an upfront payment of $500 million and an equity investment of $325 million in its common stock. The company will also receive $250 million in annual installments of $50 million over five years, along with milestone payments and royalties.
Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...
Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of ...
TODAY goes on location for "Holiday Touchdown," a new movie made in partnership with the Kansas City Chiefs and Hallmark.
Dubbed “Operation Bear Claw,” the California Department of Insurance began an investigation after an insurance company ...
No. 16 Colorado is bringing an 'iced out' look to Arrowhead Stadium this weekend for their critical Big 12 showdown against ...
Could Helldivers 2 learn something valuable from Bungie's approach to franchise building? The answer might surprise you.
Just as the Colorado balloon was filling up with current success and future possibilities, Kansas popped it on Saturday at ...
The Chiefs are in detailed financial conversations regarding sites in Kansas and Missouri, including their current one at the ...
The Jayhawks answered with a touchdown of their own and finally forced a Colorado three-and-out. On KU’s second drive of the ...
We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to Analysts. In this article, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback